Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.The £3 ...

PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million ...

HOUSTON, TX / ACCESSWIRE / September 27, 2024 / MasterWord is honored to announce its partnership with UNESCO, within its ...

SmartHMS, a leading healthcare management solutions provider based in India, is proud to announce the ongoing success and ...

The global diabetic gastroparesis treatment market is poised for significant growth, driven by the increasing prevalence of ...

Epitopea, a transatlantic cancer immunotherapy company, and CQDM are proud to announce the launch of a collaborative research project between Epitopea and Université de Montréal (UdeM), a leading ...

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced a new strategic collaboration with ...

Today is European Myeloma Day, a date dedicated to raising awareness of key issues affecting myeloma patients across Europe. This year, Myeloma Patients Europe (MPE) is highlighting the role of ...

Humaneva CEO - Tomasz D?browski WARSAW, Poland, September 27, 2024 (Newswire.com) - Humaneva Inc. has entered into a ...

BERLIN, GERMANY, September 26, 2024 – OMEICOS, a biopharmaceutical company developing first-in-class small molecule therapeutics, today announced the completion of enrollment in its multi-center, open ...

Scientists now have a mathematical measure for 250 million manuscripts ~ As part of its commitment to improving transparency in scientific publishing, Open Access science company DeSci Labs has ...

Indicated for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS)  Leiden, the Netherlands, September 26, 2024: Pharming Group ...